Equillium Quarterly Income Statements Chart
Quarterly
|
Annual
Equillium Quarterly Income Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 10,689,000 | 4,392,000 | 12,161,000 | 13,853,000 | 8,879,000 | 9,211,000 | 8,870,000 | ||||||
yoy | 20.39% | -52.32% | 37.10% | ||||||||||
qoq | 143.37% | -63.88% | -12.21% | 56.02% | -3.60% | 3.84% | |||||||
operating expenses: | |||||||||||||
research and development | 4,083,000 | 9,743,000 | 7,315,000 | 9,562,000 | 10,808,000 | 9,272,000 | 9,184,000 | 8,974,000 | |||||
general and administrative | 2,145,000 | 3,737,000 | 1,775,000 | 3,278,000 | 3,145,000 | 3,715,000 | 3,227,000 | 3,519,000 | |||||
total operating expenses | 6,228,000 | 13,480,000 | 9,090,000 | 12,840,000 | 13,953,000 | 12,987,000 | 12,411,000 | 12,493,000 | |||||
income from operations | -6,228,000 | -2,791,000 | -4,698,000 | -679,000 | -100,000 | -4,108,000 | -3,200,000 | -3,623,000 | |||||
yoy | 6128.00% | -32.06% | 46.81% | -81.26% | |||||||||
qoq | 123.15% | -40.59% | 591.90% | 579.00% | -97.57% | 28.37% | -11.68% | ||||||
operating margin % | -26.11% | -106.97% | -5.58% | -0.72% | -46.27% | -34.74% | -40.85% | ||||||
other income, net: | |||||||||||||
interest income | 122,000 | 439,000 | 239,000 | 331,000 | 371,000 | 639,000 | 517,000 | 551,000 | |||||
other income | 367,000 | -382,000 | -974,000 | 341,000 | 197,000 | -179,000 | 357,000 | -142,000 | |||||
total other income | 489,000 | 57,000 | -735,000 | 672,000 | 568,000 | 228,000 | 874,000 | 409,000 | |||||
net income | -5,739,000 | -2,734,000 | -5,794,000 | -7,000 | 468,000 | -3,940,000 | -2,342,000 | -3,710,000 | |||||
yoy | -1326.28% | -30.61% | 147.40% | -99.81% | |||||||||
qoq | 109.91% | -52.81% | 82671.43% | -101.50% | -111.88% | 68.23% | -36.87% | ||||||
net income margin % | -25.58% | -131.92% | -0.06% | 3.38% | -44.37% | -25.43% | -41.83% | ||||||
other comprehensive income, net: | |||||||||||||
unrealized loss on available-for-sale securities | -22,000 | ||||||||||||
foreign currency translation gain | -346,000 | 305,000 | 793,000 | -275,000 | -166,000 | 133,000 | -348,000 | 99,000 | |||||
total other comprehensive income | -346,000 | 283,000 | 784,000 | -254,000 | -172,000 | 229,000 | -318,000 | 118,000 | |||||
comprehensive loss | -6,085,000 | -2,451,000 | -5,010,000 | -261,000 | -3,711,000 | -2,660,000 | -3,592,000 | ||||||
net income per share | -0.08 | -0.17 | 0 | -0.11 | -0.06 | -0.11 | |||||||
basic | -0.16 | 0.01 | |||||||||||
diluted | -0.16 | 0.01 | |||||||||||
weighted-average number of common shares outstanding: | |||||||||||||
basic | 35,719,317 | 35,292,035 | |||||||||||
diluted | 35,719,317 | 36,589,774 | |||||||||||
net income per share | -0.08 | -0.17 | 0 | -0.11 | -0.06 | -0.11 | |||||||
weighted-average number of common shares outstanding, basic and diluted | 35,254,752 | 35,357,641 | 35,424,388 | 34,414,149 | 34,726,384 | 34,878,700 | |||||||
interest expense | -232,000 | ||||||||||||
income before income taxes | -568,250 | -7,000 | 468,000 | -3,880,000 | -2,607,250 | -3,214,000 | |||||||
income tax expense | 60,000 | 16,000 | 496,000 | ||||||||||
unrealized gain on available-for-sale securities | -9,000 | 21,000 | -6,000 | 96,000 | 30,000 | 19,000 | |||||||
comprehensive income | 296,000 | ||||||||||||
acquired in-process research and development |
We provide you with 20 years income statements for Equillium stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Equillium stock. Explore the full financial landscape of Equillium stock with our expertly curated income statements.
The information provided in this report about Equillium stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.